Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01286051 · ClinicalTrials.gov registry record · NA
Single Injection of Ganirelix in Gonadotropin Intrauterine Insemination (IUI) Cycles
A NA study of Compare Pregnancy Rates Between FSH Stimulation and FSH and and GnRH Antagonist, sponsored by Houston Fertility Institute.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT01286051 is a NA study of Compare Pregnancy Rates Between FSH Stimulation and FSH and and GnRH Antagonist that has completed, run by Houston Fertility Institute. The registered enrollment target is 80 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01286051, a NA study of Compare Pregnancy Rates Between FSH Stimulation and FSH and and GnRH Antagonist, has completed, sponsored by Houston Fertility Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
Ovulation induction (OI) using gonadotropins is one of the most widely prescribed treatments of infertility. One common problem encountered while attempting OI using gonadotropins is premature ovulation. The purpose of this study is to examine the effect of a single injection of a medication, called ganirelix, to prevent premature ovulation. Patients will be divided into two groups. In the first group, gonadotropins will be used to stimulate the ovaries. In the second group gonadotropins will be used in addition to a single injection of ganirelix, a gonadotropin releasing hormone (GnRH) antagonist. Pregnancy rates will be compared between groups.
Conditions Studied
Interventions
- DRUG Follistim administration
- DRUG Follistim plus Ganirelix
Study Locations (1)
Texas
- Houston Fertility Institute - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2011-01 |
| Est. Completion | 2012-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01286051
The ClinicalTrials.gov registry entry for NCT01286051 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Houston Fertility Institute, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Compare Pregnancy Rates Between FSH Stimulation and FSH and appearing as the primary indexed condition, and to 2 interventions - of which Follistim administration is the first listed.
NCT01286051 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT01286051 about?
NCT01286051 is a clinical study titled "Single Injection of Ganirelix in Gonadotropin Intrauterine Insemination (IUI) Cycles". Ovulation induction (OI) using gonadotropins is one of the most widely prescribed treatments of infertility. One common problem encountered while attempting OI using gonadotropins is premature ovulation. The purpose of this study is to examine the effect of a single injection of a medication, called...
What is the current status of trial NCT01286051?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2011-01. Estimated completion is 2012-09.
What conditions does trial NCT01286051 study?
This clinical trial studies the following conditions: Compare Pregnancy Rates Between FSH Stimulation and FSH and, GnRH Antagonist.
What interventions are being tested in trial NCT01286051?
The interventions under investigation include: Follistim administration (DRUG), Follistim plus Ganirelix (DRUG).
Who is sponsoring clinical trial NCT01286051?
This trial is sponsored by Houston Fertility Institute, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01286051 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Compare Pregnancy Rates Between FSH Stimulation and FSH and
All registered trials for this condition
GnRH Antagonist
All registered trials for this condition
Texas
All trials with a study site in Texas
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.